Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study

BACKGROUND: Loss of function of triggering receptor expressed on myeloid cell 2 (TREM2), a key receptor selectively expressed by microglia in the brain, contributes to the development of Alzheimer’s disease (AD). Whether TREM2 levels are pathologically altered during the preclinical phase, and wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ling-Zhi, Tan, Lan, Bi, Yan-Lin, Shen, Xue-Ning, Xu, Wei, Ma, Ya-Hui, Li, Hong-Qi, Dong, Qiang, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149923/
https://www.ncbi.nlm.nih.gov/pubmed/32276587
http://dx.doi.org/10.1186/s13024-020-00374-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149923/
https://www.ncbi.nlm.nih.gov/pubmed/32276587
http://dx.doi.org/10.1186/s13024-020-00374-8

Ejemplares similares